GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Short-Term Debt

Star Lake Bioscience Co (SHSE:600866) Short-Term Debt : ¥1,316 Mil (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Short-Term Debt?

Star Lake Bioscience Co's Short-Term Debt for the quarter that ended in Mar. 2024 was ¥1,316 Mil.

Star Lake Bioscience Co's quarterly Short-Term Debt declined from Sep. 2023 (¥1,606 Mil) to Dec. 2023 (¥1,201 Mil) but then increased from Dec. 2023 (¥1,201 Mil) to Mar. 2024 (¥1,316 Mil).

Star Lake Bioscience Co's annual Short-Term Debt declined from Dec. 2021 (¥2,558 Mil) to Dec. 2022 (¥2,004 Mil) and declined from Dec. 2022 (¥2,004 Mil) to Dec. 2023 (¥1,201 Mil).


Star Lake Bioscience Co Short-Term Debt Historical Data

The historical data trend for Star Lake Bioscience Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Short-Term Debt Chart

Star Lake Bioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 232.70 167.50 2,558.27 2,004.21 1,201.09

Star Lake Bioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,579.51 2,157.78 1,606.34 1,201.09 1,315.59

Star Lake Bioscience Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Star Lake Bioscience Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Star Lake Bioscience Co (SHSE:600866) Business Description

Traded in Other Exchanges
N/A
Address
No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
Executives
Chen Wu Director
Liu Xian Yi Director
Liao Jie Ming senior management
Chen Chao Ju Director
Li Qing Lin Supervisors
Zhong Zi Rong Director

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines